• Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Assessing the Low Influenza Vaccination Coverage Rate Among Healthcare Personnel in India: A Review of Obstacles, Beliefs, and Strategies

    May 1, 2020, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsules Compared With Immediate-Release Phenytoin Capsules for Patients With Epilepsy in Thailand

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • Population Aging, Technological Innovation, and the Growth of Health Expenditure: Evidence From Patients With Type 2 Diabetes in Taiwan

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers

    May 1, 2020, 00:00

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    May 1, 2020, 00:00

  • Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements

    May 1, 2020, 00:00

  • Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • Editorial Board

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • PNS54 AUDITORIA SOCIAL COMO FERRAMENTA DE ANALISE DA QUALIDADE DO ATENDIMENTO NA SAUDE

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PND12 WORK PRODUCTIVITY AND DAILY ACTIVITIES IMPAIRMENT (WPAI) IN CHILEAN PATIENTS WITH MIGRAINE: PERSPECTIVES ON INDIRECT-COSTS DRIVERS

    Oct 1, 2019, 00:00

  • PNS4 TRENDS FOR INTRODUCTION OF APPROVED DRUGS IN NETWORK META-ANALYSIS

    Oct 1, 2019, 00:00

  • PRO8 PROFILAXIS EN HEMOFILIA A CON INHIBIDORES EN COLOMBIA, ¿ES POSIBLE CONTAR CON TRATAMIENTOS QUE GENEREN AHORROS AL SISTEMA DE SALUD?

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PNS9 BUDGET IMPACT OF NEW RECOMMENDATION FOR ATROPINIZATION IN BRAZILIAN GUIDELINES FOR ANTICOLINESTARASIS INTOXICATION

    Oct 1, 2019, 00:00

  • PSY4 BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN COLOMBIA AND BRAZIL

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PCN7 COSTOS DE LOS EVENTOS ADVERSOS ASOCIADOS CON EL TRATAMIENTO DEL MIELOMA MULTIPLE REFRACTARIO RECIDIVANTE (MMRR) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PCN41 IMPACT OF DISEASE RELATED GROUP IN BREAST CANCER TREATMENT IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PNS59 IMPACTO DEL MODELO DE RIESGO COMPARTIDO EN LA TASA DE EVENTOS HOSPITALARIOS DE UN SEGURO VOLUNTARIO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PIH9 IMPACTO ECONOMICO DE ANEMIA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PDB4 COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PDB1 CALIDAD DE VIDA ASOCIADA CON OBESIDAD EN PACIENTES MEXICANOS

    Oct 1, 2019, 00:00

  • PCN39 ACCESS TO MEDICAL INTERVENTIONS IN BRAZIL: THE ROLE OF CLINICAL RESEARCH AND OF HEALTH JUDICIALIZATION

    Oct 1, 2019, 00:00

  • PRO13 IMPACT OF CAREGIVER EXPERIENCE AND HRQOL IN LATER-ONSET SPINAL MUSCULAR ATROPHY (SMA): RESULTS FROM THE PHASE 3 CHERISH TRIAL

    Oct 1, 2019, 00:00

  • PCV9 IMPACTO CLINICO Y ECONOMICO DE LAS ENFERMEDADES CARDIOVASCULARES (ECV) EN LA POBLACION ADULTA DENTRO DEL SISTEMA DE SALUD DE MEXICO.

    Oct 1, 2019, 00:00

  • PNS23 EPIDEMIOLOGY OF MYELOPROLIFERATIVE DISORDERS: REAL WORLD DATA STUDY IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN44 DESIGUALDADES EN EL DIAGNÓSTICO DE CÁNCER DE CÉRVIX EN LAS REGIONES DE COLOMBIA

    Oct 1, 2019, 00:00

  • PNS44 COORDENAÇÃO DE CUIDADOS DE SAÚDE ATRAVÉS DE UM APLICATIVO MÓVEL COMO FATOR DE MELHOR RESULTADO CLÍNICO E REDUÇÃO DE CUSTOS

    Oct 1, 2019, 00:00

  • PNS29 CHANGING OF HEALTH CARE TOURISM AND ITS RECOVERING ROLE FOR ECONOMY

    Oct 1, 2019, 00:00

  • PRS4 HEALTH TECHNOLOGY ASSESSMENT OF DUPILUMAB IN SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PUK7 ANALISIS DE EFECTIVIDAD Y SEGURIDAD DE MIRABEGRON EN PACIENTES CON SINDROME DE VEJIGA HIPERACTIVA

    Oct 1, 2019, 00:00

  • PDB3 PHARMACIST LED INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC PATIENTS AND ITS RELATIONSHIP WITH PATIENT DEMOGRAPHICS ON EQ-5D DOMAINS AND VAS SCORE

    Oct 1, 2019, 00:00

  • PIN3 COSTS AND CONSEQUENCES OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PNS35 THE EFFECT OF FINANCIAL INCENTIVE ON RETAINING DENTISTS IN RURAL AREAS IN THAILAND

    Oct 1, 2019, 00:00

  • PRO14 COMPARAR A INCIDÊNCIA DE COMORBIDADES NO TRATAMENTOS DE MIELOMA MÚLTIPLO ENTRE AS TERAPIAS DO SISTEMA DE SAÚDE BRASILEIRO (SUS) COM AS AINDA NÃO INCORPORADAS

    Oct 1, 2019, 00:00

  • PMS11 EPIDEMIOLOGY, USE OF RESOURCES AND COST OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ARGENTINA: AN EXTENSIVE REVIEW WITH EXPERT ELICITATION

    Oct 1, 2019, 00:00

  • PDG11 IMPLEMENTATION OF INDICATORS IN THE PROCESS OF ACQUISITION OF MEDICINES IN THE HOSPITAL UNITS OF THE STATE SECRETARIAT OF HEALTH OF SANTA CATARINA: THE USE OF THE ECONOMIC RATIO INDEX

    Oct 1, 2019, 00:00

  • PCN62 PRELIMIANARY ANALYSIS OF TIROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA A FIVE YEARS FOLLOW-UP FROM A REAL WORLD COHORT

    Oct 1, 2019, 00:00

  • PNS53 DESCRIPTION OF CLINICAL CHARACTERISTICS AND SELF REPORTED WILLINGNESS TO PAY FOR NEW TREATMENTS IN COLOMBIAN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

    Oct 1, 2019, 00:00

  • CV4 EVALUACION DE LOS MOTIVOS DE LA OMISION DE RETIROS DE MEDICAMENTOS PENDIENTES EN LA OFICINA DE FARMACIA. POSIBLES SOLUCIONES

    Oct 1, 2019, 00:00

  • PCN17 COSTO-EFECTIVIDAD DE AFATINIB COMO PRIMERA LÍNEA EN EL TRATAMIENTO DEL CÁNCER DE PULMÓN DE CÉLULAS NO PEQUEÑAS AVANZADO CON MUTACIÓN POSITIVA DEL RECEPTOR DEL FACTOR DE CRECIMIENTO EPIDÉRMICO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PND5 COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING SOLITAIRE STENT RETRIEVER IN COMBINATION WITH INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR (IV-TPA) VERSUS IV-TPA ALONE FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE DUE TO LARGE VESSEL OCC ...

    Oct 1, 2019, 00:00

  • PSU3 DETERMINACION DE CAMBIOS QUERATOMETRICOS POST QUIRURGICOS EN PACIENTES SOMETIDOS A PRK O LASIK MEDIANTE LASER EXCIMER VISX STAR S4IR

    Oct 1, 2019, 00:00

  • PMS3 PSYCHOLOGY CONSULTATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS - A LOW-COST INTERVENTION WITH GREAT BENEFITS

    Oct 1, 2019, 00:00

  • PNS46 ATENCION VIRTUAL EN SALUD: DE LA ESTRATEGIA A LA TACTICA

    Oct 1, 2019, 00:00

  • PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY

    Oct 1, 2019, 00:00

  • PRO10 EXPERIENCIA INTERNACIONAL EN EL USO DE ANÁLISIS DE DECISIÓN MULTICRITERIO (MCDA) PARA EVALUAR MEDICAMENTOS HUÉRFANOS: SCOPING REVIEW

    Oct 1, 2019, 00:00

  • TP4 REAL-WORLD PATIENT CHARACTERISTICS AND OUTCOMES OF RESECTED STAGE III MELANOMA PATIENTS IN ARGENTINA AND BRAZIL

    Oct 1, 2019, 00:00

  • PCN28 OVARIAN CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PSU7 COST-EFFECTIVENESS ANALYSIS OF APIXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER HIP OR KNEE REPLACEMENT SURGERY IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCV8 COST-EFFECTIVENESS ANALYSIS OF A RHEOLYTIC THROMBECTOMY SYSTEM FOR THE TREATMENT OF DEEP VEIN THROMBOSIS IN MEXICO

    Oct 1, 2019, 00:00

  • PMH8 EXPERIENCES AND HEALTH NEEDS OF ASYLUM SEEKERS AND REFUGEES OF LATIN AMERICAN ORIGIN IN CHILE

    Oct 1, 2019, 00:00

  • PBI10 REAL WORLD SWITCHING PATTERNS OF ETANERCEPT ORIGINAL AND BIOSIMILAR IN GERMANY

    Oct 1, 2019, 00:00

  • PMH1 COST-OF-ILLNESS STUDIES FOR DEPRESSION AND BIPOLAR DISORDER IN LATIN AMERICA: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • CE4 TRATAMIENTOS PARA LOS PACIENTES CON ESCLEROSIS MULTIPLE REMITENTE RECURRENTE CON ALTA ACTIVIDAD DE LA ENFERMEDAD: ANALISIS COSTO EFECTIVIDAD EN MEXICO

    Oct 1, 2019, 00:00

  • CN4 ANÁLISIS DE COSTO-UTILIDAD E IMPACTO PRESUPUESTARIO DE LA ENZALUTAMIDA PARA EL TRATAMIENTO DEL CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN NO METASTÁSICO (CPRCNM) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PBI4 COMPORTAMIENTO DE USO DE TERAPIA BIOLÓGICA Y COSTOS ASOCIADOS DE UN PROGRAMA DE ATENCIÓN EN PACIENTES CON DIAGNASTICO DE ARTRITIS REUMATOIDE EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN48 HEALTH TECHNOLOGY ASSESSMENT DECISIONS IN ONCOLOGY-RELATED TECHNOLOGIES IN BRAZIL: AN ASSESSMENT CONITEC'S RECOMMENDATIONS FROM 2012-2018

    Oct 1, 2019, 00:00

  • PSU2 EFECTIVIDAD Y SEGURIDAD DEL USO DE LOS IMPLANTES DE AHMED, MOLTENO Y BAERVELDT EN PACIENTES OPERADOS CON GLAUCOMA CRONICO: UN META-ANALISIS EN RED

    Oct 1, 2019, 00:00

  • PIN6 O IMPACTO ECONOMICO NA AVALIACAO DO INFECTOLOGISTA NO PROGRAMA DE GESTAO CLINICA DO USO DE ANTIMICROBIANOS EM HOSPITAL PRIVADO DE FORTALEZA- CE, BRASIL

    Oct 1, 2019, 00:00

  • CN2 EVALUACIÓN DE COSTO-EFECTIVIDAD DE LA ENZALUTAMIDA (ENZA) FRENTE A LA ABIRATERONA (ABI) PARA EL TRATAMIENTO DE PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN METASTÁSICO (CPRCM) ANTES DEL USO DE DOCETAXEL EN EL INSTITUTO ME ...

    Oct 1, 2019, 00:00

  • PCN38 SYSTEMATIC REVIEW OF RISK SHARING AGREEMENT IN ONCOLOGY: ADVANCES OR MORE OF THE SAME?

    Oct 1, 2019, 00:00

  • EP2 PUBLIC HEALTH AND ECONOMIC IMPACT OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • CL2 EFFECTIVENESS OF TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN THE COLOMBIAN POPULATION WITH CHRONIC HEPATITIS C

    Oct 1, 2019, 00:00

  • PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM

    Oct 1, 2019, 00:00

  • PCN47 PEG-ASPARAGINASE E L-ASPARAGINASE NATIVA DE ESCHERICHIA COLI NO TRATAMENTO FARMACOLOGICO DA LEUCEMIA LINFOBLASTICA AGUDA EM CRIANCAS E ADOLESCENTES: UMA REVISAO SISTEMATICA

    Oct 1, 2019, 00:00

  • PIN11 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Oct 1, 2019, 00:00

  • PDB14 LOVASTATIN, ATORVASTATIN AND ROSUVASTATIN CONSUMPTION IN COLOMBIA FROM 2010 TO 2017

    Oct 1, 2019, 00:00

  • PMU8 DIFERENCIAS EN LA MORTALIDAD SEGUN LUGAR DE OCURRENCIA Y REGIMEN DE SALUD EN EL CARIBE COLOMBIANO, 2016

    Oct 1, 2019, 00:00

  • PMU2 COSTOS DIRECTOS MÉDICOS EN COLOMBIA DESCRITOS EN EL ESTUDIO COMPASS: EVENTOS CARDIACOS AGUDOS MAYORES (MACE) Y EVENTOS ISQUEMICOS SEVEROS EN EXTREMIDADES (MALE)

    Oct 1, 2019, 00:00

  • PSY8 CURRENT PRACTICE AND RESOURCE USE ASSOCIATED WITH TREATMENT OF VENOUS THROMBOEMBOLISM DISEASE IN SOCIAL SECURITY SECTOR OF ARGENTINA

    Oct 1, 2019, 00:00

  • TP1 TRATAMIENTO DEL CANCER DE MAMA ESTADIO IV, ANÃLISIS DE LOS DATOS REPORTADOS A LA CUENTA DE ALTO COSTO. COLOMBIA 2017

    Oct 1, 2019, 00:00

  • PMD4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SISTEMA DE SALUD PUBLICO DE MENDOZA, ARGENTINA

    Oct 1, 2019, 00:00

  • PSY2 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA PERUANA

    Oct 1, 2019, 00:00

  • PCN1 EFECTIVIDAD Y SEGURIDAD DEL ESQUEMA DABRAFENIB-TRAMETINIB EN EL TRATAMIENTO DEL MELANOMA AVANZADO/METASTÁSICO IRRESECABLE CON MUTACIÓN BRAF V600: REVISIÓN SISTEMÁTICA DE LA LITERATURA Y METANÁLISIS EN RED

    Oct 1, 2019, 00:00

  • PMH7 COST-EFFECTIVENESS AND INCORPORATION PRICE OF ARIPIPRAZOLE FOR SCHIZOPHRENIA IN BRAZIL: A SUBSTITUTE TECHNOLOGY APPROACH

    Oct 1, 2019, 00:00

  • PRS2 COST ANALYSIS FOR THE TREATMENT OF SEVERE UNCONTROLLED BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PCN59 SUBJECT TRAINING IS NEEDED FOR KEY TERMINOLOGY IN ONCOLOGY CLINICAL TRIALS

    Oct 1, 2019, 00:00

  • PCV4 ANNUAL HEALTH INSURANCE TREATMENT COST OF HYPERTENSIVE RENAL DISEASE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PDG8 COST-EFFECTIVENESS ANALYSIS OF MIDOSTAURIN (MIDO) + INTENSIVE CHEMOTHERAPY (SOC) FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH FLT3 MUTATION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN18 ANTINEOPLASICOS ORAIS NA PRIMEIRA LINHA DE TRATAMENTO DE LEUCEMIA MIELOIDE CRONICA: UMA ANALISE DE CUSTO

    Oct 1, 2019, 00:00

  • PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING

    Oct 1, 2019, 00:00

  • PMD12 HOW MUCH CAN COLOMBIAN HOSPITALS EARN FOR EACH THERAPEUTIC PLASMA EXCHANGE (TPE) PROCEDURE? A MULTI-CENTER, COST COMPARISON STUDY BETWEEN CENTRIFUGAL AND MEMBRANE SYSTEMS

    Oct 1, 2019, 00:00

  • PSY5 QUALITY OF LIFE OF INDIVIDUALS WITH PSORIASIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PGI1 EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PDG12 EXPERIENCIA INTERNACIONAL EN VALOR TERAPÉUTICO Y PRECIO BASADO EN VALOR. REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PMU7 POPULATION HEALTH IMPACT MODEL

    Oct 1, 2019, 00:00

  • PRS8 HEALTH RESOURCE USE OF COPD PATIENTS IN THE BRAZILIAN PRIVATE HEALTHCARE SETTING

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • PNS47 ANÁLISIS PARA LA IMPLEMENTACIÓN DE NUEVOS MODELOS DE ACCESO PARA EL SISTEMA NACIONAL DE SALUD DEL ECUADOR

    Oct 1, 2019, 00:00

  • PIT6 SELF-INFLICTED LESIONS IN BRAZIL: A DESCRIPTIVE ANALYSIS BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PIN16 ESTIMATED ANNUAL IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IMMUNIZATION PROGRAM IN COLOMBIA (2011-2018)

    Oct 1, 2019, 00:00

  • PCV15 GOOD PRACTICES ASSESSMENT FOR CARDIAC SURGERIES: A REAL WORLD ANALYSIS

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • Financial Disclosure Information

    Oct 1, 2019, 00:00

  • PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PND2 TREATMENTS FOR HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS: COST-EFFECTIVENESS ANALYSIS IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMD3 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SANATORIO FINOCHIETTO DE ARGENTINA

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PDB8 IMPACTO ECONOMICO DE LA DIABETES MELLITUS TIPO II EN EL PERU EN EL ANHO 2017

    Oct 1, 2019, 00:00

  • PMS13 A ROUTE FOR THE CORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS - AN OPPORTUNITY TO AVOID MISDIAGNOSIS AND COSTS ASSOCIATED

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • HT4 EXPERIENCIAS INTERNACIONALES ACERCA DE LOS CRITERIOS DE DECISIÓN USADOS EN LA PRIORIZACIÓN DE LAS TECNOLOGÍAS DE SALUD

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • PMH9 IMPACTO DE FACTORES SOCIOLOGICOS EN LA CALIDAD DE VIDA DE ADULTOS MAYORES INSTITUCIONALIZADOS CON DEPRESION: REVISION SISTEMATICA

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • PMH6 COST-EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS FOR FIRST- AND SECOND-LINE TREATMENT OF SCHIZOPHRENIA IN BRAZIL

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PCV10 EPIDEMIOLOGICAL STUDY DESIGN TO UNDERSTAND CARDIOVASCULAR RISK FACTORS AND TREATMENT IN GENERAL PRACTICE PATIENTS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PCN23 IMPACTO ECONOMICO DE CANCER DE CUELLO UTERINO Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00

  • PNS10 THE PENALTY OF MATERNITY FOR LABOR MARKET IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PNS57 REAL WORLD EVIDENCE LANDSCAPE IN LATIN AMERICA HEALTH CARE DECISION MAKING: EXPLORING UNDERSTANDING, ACCEPTABILITY AND USE

    Oct 1, 2019, 00:00

  • PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN14 COSTOS INDIRECTOS DEL CANCER DE MAMA EN COLOMBIA: 1990-2016.

    Oct 1, 2019, 00:00

  • PIH1 COSTOS DIRECTOS FARMACÉUTICOS EN PACIENTES ANCIANOS CON POLIFARMACIA EXTREMA MAYOR DE 20 MEDICAMENTOS EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCV13 EFECTIVIDAD DEL CATETER VENOSO DE INSERCION CENTRAL VS EL CATETER VENOSO CENTRAL DE INSERCION PERIFERICA EN EL TRATAMIENTO DE PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS.

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • PRO3 DIRECT COSTS OF HEMOPHILIA CARE, THE CASE OF A HEALTH INSURER IN COLOMBIA

    Oct 1, 2019, 00:00

  • PDB16 AVALIAÇÃO DA EFICÁCIA E SEGURANÇA DO USO DO METIMAZOL EM COMPARAÇÁO A PROPILTIOURACILA PARA HIPERTIREOIDISMO

    Oct 1, 2019, 00:00

  • PCN63 COSTOS ASOCIADOS AL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN EL REGIMEN CONTRIBUTIVO

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • PNS12 THE IMPACT OF THE POSTPONEMENT OF MATERNITY ON WOMEN'S INCOME IN BRAZIL

    Oct 1, 2019, 00:00

  • PSY3 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA COLOMBIANA

    Oct 1, 2019, 00:00

  • PIH19 CONTRASTE DE MODELOS DE PROBABILIDAD DICOTOMICOS PARA LA ESTIMACION DE PARTOS Y CESAREAS EN UNA ENTIDAD PROMOTORA DE SALUD COLOMBIANA

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PNS22 DESCRIBING GAPS IN ACCESS TO HEALTHCARE BETWEEN INTERNATIONAL MIGRANTS AND THE CHILEAN-BORN POPULATION

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »